Emily J. Johns - 28 Aug 2026 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Reporting relationship
Chief Administrative Officer
Issuer ticker
NMTC
Reported as of
28 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Aug 2026, 17:29:13 UTC
Prior SEC filing
03 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Emily Johns

Key filing fact

Emily J. Johns filed Form 4 for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) on 28 Aug 2026.

Key facts

  • This page summarizes Emily J. Johns's Form 4 filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 28 Aug 2026, 17:29.

Change

  • Previous filing in this sequence was filed on 03 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002067635 Primary reporting owner

Johns Emily J.

Relationship
Chief Administrative Officer
Address
7599 ANAGRAM DR., EDEN PRAIRIE
Signature
/s/ Emily Johns
Signature date
28 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NMTC transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
Shares
+12,500
Change %
Price
$0.000000*
Shares after
12,500
Date
28 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$1.77
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .